Branded Specialty Portfolio (MENA)
Oncology, Diabetes, Cardiovascular, Respiratory
Marketed / Line ExtensionsActive
Key Facts
Indication
Oncology, Diabetes, Cardiovascular, Respiratory
Phase
Marketed / Line Extensions
Status
Active
Company
About Hikma
Hikma is a multinational pharmaceutical company with a mission to improve global access to high-quality medicines. In 2025, it achieved a significant milestone by becoming the largest pharmaceutical company in the MENA region by sales, underscoring the strength of its Branded division. Its strategy focuses on leveraging distinct competitive advantages across its three business segments—Injectables, Generics, and Branded—while investing in R&D, manufacturing, and leadership to drive consistent, profitable growth, particularly in optimizing its Injectables business.
View full company profile